| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|
| cerium | [no description available] | medium | 2 | 0 | f-block element atom;
lanthanoid atom | |
| ceric oxide | [no description available] | medium | 2 | 0 | cerium molecular entity;
metal oxide | |
| chitosan | [no description available] | medium | 1 | 0 | | |
| histamine | [no description available] | medium | 1 | 0 | aralkylamino compound;
imidazoles | human metabolite;
mouse metabolite;
neurotransmitter |
| methylene blue | [no description available] | medium | 4 | 0 | organic chloride salt | acid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer |
| uracil | [no description available] | medium | 1 | 0 | pyrimidine nucleobase;
pyrimidone | allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prodrug;
Saccharomyces cerevisiae metabolite |
| pyruvic acid | [no description available] | medium | 1 | 0 | 2-oxo monocarboxylic acid | cofactor;
fundamental metabolite |
| 6-amino-1,3-dimethyl uracil | [no description available] | medium | 1 | 0 | | |
| 2,3,4,6-tetrachlorophenol | [no description available] | medium | 1 | 0 | tetrachlorophenol | xenobiotic metabolite |
| caprolactam | [no description available] | medium | 1 | 0 | caprolactams | human blood serum metabolite |
| methane | [no description available] | medium | 3 | 0 | alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound | bacterial metabolite;
fossil fuel;
greenhouse gas |
| metallothionein | [no description available] | medium | 3 | 0 | | |
| lead | [no description available] | medium | 9 | 0 | carbon group element atom;
elemental lead;
metal atom | neurotoxin |
| atrazine | [no description available] | medium | 1 | 0 | chloro-1,3,5-triazine;
diamino-1,3,5-triazine | environmental contaminant;
herbicide;
xenobiotic |
| zinc oxide | [no description available] | medium | 12 | 0 | zinc molecular entity | |
| cadmium chloride | [no description available] | medium | 16 | 0 | cadmium coordination entity | |
| bromochloroacetic acid | [no description available] | medium | 1 | 0 | 2-bromocarboxylic acid;
monocarboxylic acid;
organochlorine compound | |
| citrulline | [no description available] | medium | 1 | 0 | amino acid zwitterion;
citrulline | Daphnia magna metabolite;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
protective agent;
Saccharomyces cerevisiae metabolite |
| silver | [no description available] | medium | 5 | 0 | copper group element atom;
elemental silver | Escherichia coli metabolite |
| arsenic trioxide | [no description available] | medium | 3 | 0 | | |
| cadmium | [no description available] | medium | 76 | 0 | cadmium molecular entity;
zinc group element atom | |
| direct yellow-12 | [no description available] | medium | 1 | 0 | | |
| mercuric oxide | [no description available] | medium | 1 | 0 | | |
| tin | [no description available] | medium | 1 | 0 | carbon group element atom;
elemental tin;
metal atom | micronutrient |
| mercury | [no description available] | medium | 1 | 0 | elemental mercury;
zinc group element atom | neurotoxin |
| saccharin | [no description available] | medium | 1 | 0 | 1,2-benzisothiazole;
N-sulfonylcarboxamide | environmental contaminant;
sweetening agent;
xenobiotic |
| chromium | [no description available] | medium | 1 | 0 | chromium group element atom;
metal allergen | micronutrient |
| ether | [no description available] | medium | 1 | 0 | ether;
volatile organic compound | inhalation anaesthetic;
non-polar solvent;
refrigerant |
| acetone | [no description available] | medium | 1 | 0 | ketone body;
methyl ketone;
propanones;
volatile organic compound | EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent |
| cadmium sulfide | [no description available] | medium | 8 | 0 | cadmium molecular entity | |
| nad | [no description available] | medium | 1 | 0 | organophosphate oxoanion | cofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite |
| methyl orange | [no description available] | medium | 2 | 0 | | |
| fluorine | [no description available] | medium | 1 | 0 | diatomic fluorine;
gas molecular entity | NMR chemical shift reference compound |
| barium | [no description available] | medium | 1 | 0 | alkaline earth metal atom;
elemental barium | |
| aluminum | [no description available] | medium | 1 | 0 | boron group element atom;
elemental aluminium;
metal atom | |
| aluminum oxide | [no description available] | medium | 3 | 0 | | |
| zirconium | [no description available] | medium | 1 | 0 | titanium group element atom | |
| ammonium hydroxide | [no description available] | medium | 1 | 0 | azane;
gas molecular entity;
mononuclear parent hydride | EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant |
| methanol | [no description available] | medium | 1 | 0 | alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound | amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite |
| cyanides | [no description available] | medium | 1 | 0 | pseudohalide anion | EC 1.9.3.1 (cytochrome c oxidase) inhibitor |
| isovitexin | [no description available] | medium | 1 | 0 | C-glycosyl compound;
trihydroxyflavone | EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite |
| ferulic acid | [no description available] | medium | 1 | 0 | ferulic acids | anti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite |
| apigenin | [no description available] | medium | 1 | 0 | trihydroxyflavone | antineoplastic agent;
metabolite |
| sodium citrate, anhydrous | [no description available] | medium | 1 | 0 | organic sodium salt | anticoagulant;
flavouring agent |
| cadmium sulfate | [no description available] | medium | 3 | 0 | cadmium salt | |
| bismuth | [no description available] | medium | 2 | 0 | metal atom;
pnictogen | |
| manganese dioxide | [no description available] | medium | 1 | 0 | manganese molecular entity;
metal oxide | |
| oxalic acid | [no description available] | medium | 1 | 0 | alpha,omega-dicarboxylic acid | algal metabolite;
human metabolite;
plant metabolite |
| gold | [no description available] | medium | 1 | 0 | copper group element atom;
elemental gold | |
| cadmium nitrate | [no description available] | medium | 1 | 0 | cadmium salt;
inorganic nitrate salt | carcinogenic agent;
genotoxin;
hepatotoxic agent |
| nitrates | [no description available] | medium | 1 | 0 | monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species | |
| boron oxide | [no description available] | medium | 1 | 0 | boron oxide | |
| erbium | [no description available] | medium | 1 | 0 | f-block element atom;
lanthanoid atom | |
| indium | [no description available] | medium | 1 | 0 | boron group element atom | |
| platinum | [no description available] | medium | 1 | 0 | elemental platinum;
nickel group element atom;
platinum group metal atom | |
| hydrogen | [no description available] | medium | 1 | 0 | elemental hydrogen;
elemental molecule;
gas molecular entity | antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite |
| gallium | [no description available] | medium | 1 | 0 | boron group element atom | |
| gallium nitride | [no description available] | medium | 1 | 0 | | |
| ferrous oxide | [no description available] | medium | 1 | 0 | iron oxide | |
| phencyclidine | [no description available] | medium | 7 | 0 | benzenes;
piperidines | anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug |
| dimercaprol | [no description available] | medium | 1 | 0 | dithiol;
primary alcohol | chelator |
| trioctyl phosphine oxide | [no description available] | medium | 2 | 0 | | |
| 2-methylpentane | [no description available] | medium | 2 | 0 | alkane | |
| tetrahydrofuran | [no description available] | medium | 2 | 0 | cyclic ether;
oxolanes;
saturated organic heteromonocyclic parent;
volatile organic compound | polar aprotic solvent |
| selenium | [no description available] | medium | 3 | 0 | chalcogen;
nonmetal atom | micronutrient |
| silver carbonate | [no description available] | medium | 1 | 0 | | |
| 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium | [no description available] | medium | 1 | 0 | | |
| molybdenum trioxide | [no description available] | medium | 1 | 0 | molybdenum oxide | |
| 5-ethylphenazine | [no description available] | medium | 1 | 0 | | |
| molybdenum | [no description available] | medium | 2 | 0 | chromium group element atom | micronutrient |
| thiazoles | [no description available] | medium | 1 | 0 | 1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene | |
| carbonates | [no description available] | medium | 2 | 0 | carbon oxoanion | |
| sulfur | [no description available] | medium | 1 | 0 | chalcogen;
nonmetal atom | macronutrient |
| cadmium carbonate | [no description available] | medium | 1 | 0 | | |
| ethylenediamine | [no description available] | medium | 1 | 0 | alkane-alpha,omega-diamine | GABA agonist |
| arsenic | [no description available] | medium | 2 | 0 | metalloid atom;
pnictogen | micronutrient |
| pd 98059 | [no description available] | medium | 1 | 0 | aromatic amine;
monomethoxyflavone | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector |
| sb 203580 | [no description available] | medium | 1 | 0 | imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent |
| tetradecanoylphorbol acetate | [no description available] | medium | 1 | 0 | acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester | antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator |
| vanadium pentoxide | [no description available] | medium | 1 | 0 | vanadium oxide | |
| tyrosine | [no description available] | medium | 1 | 0 | amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical |
| chlorine | [no description available] | medium | 1 | 0 | halide anion;
monoatomic chlorine | cofactor;
Escherichia coli metabolite;
human metabolite |
| molybdate ion | [no description available] | medium | 1 | 0 | divalent inorganic anion;
molybdenum oxoanion | Escherichia coli metabolite |
| chromates | [no description available] | medium | 1 | 0 | chromium oxoanion;
divalent inorganic anion | oxidising agent |
| nadp | [no description available] | medium | 1 | 0 | | |
| tert-butylhydroperoxide | [no description available] | medium | 1 | 0 | alkyl hydroperoxide | antibacterial agent;
oxidising agent |
| beryllium | [no description available] | medium | 1 | 0 | alkaline earth metal atom;
elemental beryllium;
metal allergen | adjuvant;
carcinogenic agent;
epitope |
| cobalt | [no description available] | medium | 1 | 0 | cobalt group element atom;
metal allergen | micronutrient |
| beryllium oxide | [no description available] | medium | 1 | 0 | beryllium molecular entity;
metal oxide | carcinogenic agent |
| ytterbium | [no description available] | medium | 1 | 0 | f-block element atom;
lanthanoid atom | |
| vanadium | [no description available] | medium | 1 | 0 | elemental vanadium;
vanadium group element atom | micronutrient |
| nickel | [no description available] | medium | 1 | 0 | metal allergen;
nickel group element atom | epitope;
micronutrient |